Sitagliptin-Metformin is a combination medication used to treat type 2 diabetes. It contains two active ingredients: sitagliptin, which belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, and metformin, which is a biguanide.

Sitagliptin works by increasing the levels of incretin hormones in the body, which help to regulate blood sugar levels by stimulating the release of insulin and decreasing the production of glucose in the liver. Metformin works by decreasing the amount of glucose produced by the liver and improving the body’s response to insulin.

This combination medication is typically prescribed for patients who have not achieved adequate blood sugar control with either sitagliptin or metformin alone. By combining these two medications, Sitagliptin-Metformin can help to lower blood sugar levels and improve overall glycemic control in patients with type 2 diabetes.

It is important to take Sitagliptin-Metformin exactly as prescribed by your healthcare provider. This medication is usually taken with meals to help reduce the risk of stomach upset. Common side effects may include diarrhea, nausea, stomach pain, and headache. It is important to monitor your blood sugar levels regularly while taking this medication and to report any unusual symptoms to your healthcare provider.

As with any medication, it is important to discuss the potential risks and benefits of Sitagliptin-Metformin with your healthcare provider before starting treatment. This medication can be a valuable tool in managing type 2 diabetes when used as part of a comprehensive treatment plan that includes diet, exercise, and regular monitoring of blood sugar levels.